US-based Dragonfly Therapeutics has announced it has signed a multi-target collaboration with AbbVie to advance immunotherapies created using its Tri-specific Natural Killer (NK) cell engager Therapies (TriNKET) technology for autoimmune and oncology indications. AbbVie has […]
Eli Lilly is set to invest $400m to boost the capacity of its manufacturing facilities at its technology centre campus in Indianapolis, Indiana, US. The move is intended to meet the increasing demand for the […]
SMi Reports: Summary of speakers announced for Pharmaceutical Microbiology 2020 in London SMi Group’s 9th Annual Pharmaceutical Microbiology Conference is set to take place on the 20th and 21st January 2020 in London. The event will provide […]
US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs for liver-related cardio-metabolic diseases. In this regard, the companies will make use of GalXC, an […]
SMi Reports: Delivery Mechanisms will be a key focus of the RNA Therapeutics conference taking place in London on 18th – 20th February 2020. SMi’s 11th annual RNA Therapeutics conference will take place in London […]